3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
6
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Breast Cancer
2
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Anxiety Disorders
1
Amyotrophic Lateral Sclerosis
1
Interventions
Platinum
4
Pemetrexed
3
Cisplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
atezolizumab
2
Radiotherapy
2
Radiation
2
pembrolizumab
1
decitabine and cedazuridine drug combination
1
cediranib
1
Radiotherapy, Intensity-Modulated
1
Cerebral Decortication
1
Carboplatin
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Injections
×
30 days
×
Clear all
No trials found.